Rallybio (RLYB)
US Market
TipRanksstock market overview Rallybio Financial Statements

Rallybio Financial Statements


Rallybio Financial Overview

Rallybio's market cap is currently ―. The company's EPS TTM is $-1.756; its P/E ratio is -6.71; Rallybio is scheduled to report earnings on November 9, 2022, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -17.25M$ -14.11M$ -12.19M$ -9.86M$ -10.66M
EBITDA$ -17.20M$ -14.07M$ -12.16M$ -9.84M$ -10.63M
Net Income Common Stockholders$ -17.58M$ -14.50M$ -12.41M$ -10.20M$ -11.13M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 112.73M$ 127.74M$ 140.23M$ 147.37M$ 161.41M
Total Assets$ 155.61M$ 169.35M$ 182.19M$ 193.87M$ 120.10M
Total Debt$ 626.00K$ 667.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -112.10M$ -127.08M$ -140.23M$ -147.37M$ -161.41M
Total Liabilities$ 7.76M$ 6.32M$ 6.58M$ 7.38M$ 189.46M
Stockholders Equity$ 0.00$ 136.00M$ 147.85M$ 163.04M$ 175.60M
Cash Flow
Free Cash Flow$ -13.57M$ -13.77M$ -10.02M$ -11.00M$ -12.85M
Operating Cash Flow$ -13.55M$ -13.73M$ -9.89M$ -10.87M$ -12.85M
Investing Cash Flow$ -7.12M$ -80.18M$ -137.00K$ -130.00K$ -1.50M
Financing Cash Flow$ 0.00$ 0.00$ -1.62M$ 85.25M$ -663.00K
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis